Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)

Market Cap	360.17M -49.9%
Revenue (ttm)	1.80B -13.0%
Net Income	3.55M -87.6%
EPS	0.01 -87.4%
Shares Out	510.87M
PE Ratio	101.61
Forward PE	n/a
Dividend	0.04 (5.55%)
Ex-Dividend Date	n/a

Volume	12,950
Open	71.80
Previous Close	71.80
Day's Range	69.70 - 71.80
52-Week Range	66.30 - 157.00
Beta	0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About Novolog (Pharm-Up 1966)

Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. The company operates through three divisions: Logistics, Healthcare Services, and Digital. The Logistics division engages in the import and distribution of pharmaceuticals and medical products; logistics of clinical trials and related services; provision of pharmaceutical services to customers; and sterilization and validation processes of consumable medical equipment. The Healthcare Services division provides personalized medicine, medical and diagnostic laboratory, and other ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1966
• Employees: 916
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: NVLG

Financial Performance

In 2025, Novolog (Pharm-Up 1966)'s revenue was 1.81 billion, a decrease of -10.70% compared to the previous year's 2.02 billion. Earnings were 4.12 million, a decrease of -89.59%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 17, 2026

Data Sources Report a data error